ABO(H) blood groups and pre-eclampsia

Peter Clark; Olivia Wu

doi:10.1160/TH08-05-0302

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 100(03): 469-474
DOI: 10.1160/TH08-05-0302

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

ABO(H) blood groups and pre-eclampsia

A systematic review and meta-analysis

Peter Clark

¹Department of Transfusion Medicine, Ninewells Hospital and Medical School, Dundee, UK

,

Olivia Wu

²Section of Geriatric Medicine and Section of Public Health and Health Policy, University of Glasgow, UK

› Author Affiliations

Abstract

PDF Download

Summary

pre-eclampsia is associated with both placental thrombosis and thrombophilia. The ABO(H) blood group influences von Willebrand factor, which is a risk factor for arterial and venous thrombosis. Over many years a number of studies have examined the relationship between ABO(H) and pre-eclampsia, but no consensus exists as to whether there is a true association. Correspondingly, a systematic review of studies reporting an association between ABO(H) blood group and pre-eclampsia syndromes was performed. From the 17 eligible studies there was no consistent link between blood group AB and pre-eclampsia, with a pooled odds ratio of group AB versus the remainder of 1.02 (95%CI 0.86 to 1.22).There was no evidence of heterogeneity and individual study estimates were relatively consistent. Comparing a combined group of non-Os (i.e.AA, AB and BB) with group O gave similar results, with a pooled odds ratio of 1.01 (95%CI 0.91 to 1.12), but with some evidence of heterogeneity (p=0.01) and individual study estimate inconsistency (I² 49%).However, no specific feature (disease definition, disease severity, date of publication, or ABO(H) distribution in controls) distinguished those few studies giving any form of positive association from the remainder. In summary, no clear association between any ABO(H) blood group and pre-eclampsia can be made from available studies. However, existing data does not allow exclusion of an effect limited to those expressing the least O(H) antigen.

Keywords

ABO(H) blood groups - pre-eclampsia - systematic review

PDF (500 kb)

References

References
1 Robertson L, Wu O, Langhorne P. et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132: 171-196.
2 Koster T, Blann AD, Briet E. et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-155.
3 Pekonen F, Rasi V, Ammala M. et al. Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb Res 1986; 43: 553-560.
4 Dunlop W, Hill L, Landon M. et al. Clinical relevance of coagulation and renal changes in pre-eclampsia. Lancet 1978; 02: 346-349.
5 Fournie A, Monrizies M, Pontonnier G. et al. Factor VIII complex in normal pregnancy, pre-eclampsia and fetal growth retardation. BJOG 1981; 88: 250-254.
6 Wu O, Bayoumi N, Vickers M. et al. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 06: 62-69.
7 Boorman K, Daley D, Dood B. The relation between the results of ABO and Rh tests and the clinical condition of 2000 mothers and infants. BJOG 1947; 54: 281-299.
8 Witsenburg C, Rosendaal F, Middledorp J. et al. Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation. Thromb Res 2005; 115: 387-392.
9 Spinillo A, Caouzzo E, Baltaro F. et al. Case-control study of maternal blood group and severe pre-eclampsia. J Hum Hypertens 1995; 09: 623-625.
10 Kmet L, Lee R, Cook L. Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields. Alberta Heritage Foundation for Medical Research; 2004
11 NHS Centres for Review and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. 2nd ed.. York: University of York; 2001
12 Stroup D, Berlin J, Morton S. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-2012.
13 May D. Maternal blood group A and pre-eclampsia. Br Med J 1973; 04: 738.
14 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 07: 177-188.
15 Higgins J, Thompson S, Deeks JJ. et al. Measuring inconsistency in meta-analysis. Br Med J 2003; 327: 557-560.
16 Higgins J, de Swiet M. Blood pressure measurement and classification in pregnancy. Lancet 2001; 357: 131-134.
17 Helewa M, Burrows R, Smith J. et al. Report of the Canadian Hypertension Society Consensus conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.. Can Med Assoc J 1997; 15: 715-725.
18 National high blood pressure education program working group on high blood pressure in pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000 183. S1-22.
19 Stern J, Egger M, Davey-Smith G. Investigating and dealing with publication and other biasis in meta-analysis. Br Med J 2001; 323: 101-105.
20 Clark P, Walker I, Govan L. et al. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 2008; 140: 236-240.
21 Andrews G. Blood groups and toxaemia of pregnancy. Br Med J 1959; 02: 806-807.
22 Clark P, O'Sullivan A, Forgan M. et al. ABO and secretor genotypes and the risk of pre-eclampsia. J Thromb Haemost 2005; 03 (Suppl. 01) P0493.
23 Lawoyin T, Ani F. Epidemiologic aspects of pre-eclampsia in Saudi Arabia. East African Med J 1996; 73: 404-406.
24 Amin N, Tahir S, Abadi N. et al. Association of blood groups with preeclamptic toxemia. Med Sci Res 1989; 17: 861-862.
25 Pearse W. ABO blood groups in obstetrics. Am J Obstet Gynecol 1957; 74: 538-542.
26 Abi-Said D, Annegers J, Combs-Cantrell D. et al. Case-control study of the risk factors for pre-eclampsia. Am J Epidemiol 1995; 142: 437-441.
27 Dickins A, Richardson J, Pike L. Further observations on ABO blood-group frequencies and toxaemia of pregnancy. Br Med J 1956; 01: 776-777.
28 Pearson M, Pinker G. ABO blood groups and toxaemia of pregnancy. Br Med J 1956; 01: 777-778.
29 Scott J, Beer A, Stastny P. Immunogenetic factors in pre-eclampsia and eclampsia. J Am Med Assoc 1976; 235: 402-404.
30 Middledorp S, van de Poel M, Bank I. et al. Unselected women with elevated levels of FVIII:C or homocysteine are not at increased risk for obstetric complications. Thromb Haemost 2004; 92: 787-790.
31 Deng L, Bremme K, Hansson L, et al. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in pre-eclampsia. Obstet Gynecol 1994; 84: 941-944.
32 Jenkins P, O'Donnell J. ABO blood group determines plasma von-Willebrand factor levels: a biological function after all. Transfusion 2006; 46: 1836-1844.
33 Harlap S, Davies A. Maternal blood group A and pre-eclampsia. Br Med J 1974; 03: 171-172.
34 Kutcipal R, Behrman S. Maternal blood groups and complications of pregnancy. Obstet Gynecol 1963; 22: 573-577.
35 Kyank V, Kulisch B. Blutgruppen, Rh-Faktor und Schwangerschaftstoxicose. Geburth Frauenheilk 1958; 18: 946-950.
36 Motavkina N, Avelichev O. Structure of the late toxicosis of pregnancy depending on the blood groups of the ABO system. Akusherstvo i Ginekologiia 1974; 03: 67-68.
37 Clark P, Brennand J, Conkie JA. et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-1170.